Clinical Trials Logo

Hearing Loss clinical trials

View clinical trials related to Hearing Loss.

Filter by:

NCT ID: NCT05636488 Not yet recruiting - Clinical trials for Noise Induced Hearing Loss

Determination of the Effects of Noise Level in the Operating Room

Start date: December 1, 2022
Phase:
Study type: Observational

The goal of this observational study is to learn about effects of noise in healthy patients undergoing elective surgery.

NCT ID: NCT05634356 Recruiting - Clinical trials for Sensorineural Hearing Loss

Social Influences on Sensorimotor Integration of Speech Production and Perception During Early Vocal Learning

Start date: October 12, 2022
Phase: N/A
Study type: Interventional

The goal of this study is to investigate the role of social factors on speech learning, including production and perception, in infants ranging in age from ~7-18 months. Infants have either typical hearing or sensorineural hearing loss. The main prediction of the study is that social reinforcement will engender improvements in vocal learning above and beyond gains in hearing in infants with hearing loss. As part of this study: - The parent and infant engage in a free play session in the playroom while the investigator cues the parent to say simple nonsense words; - Infants hear playback of the same words during a second phase.

NCT ID: NCT05633719 Not yet recruiting - Clinical trials for Solid Tumor, Childhood

Multicenter, Prospective Observational Study for Early Diagnosis, and Development of Follow-up Protocol and Hearing Rehabilitation Program for Ototoxic Hearing Loss After Chemotherapy for Pediatric Solid Cancer

Start date: December 1, 2022
Phase:
Study type: Observational [Patient Registry]

More than half of all pediatric cancer in Korea are solid cancer. For the treatment of solid cancer, multidisciplinary methods such as surgery, chemotherapy, and radiation therapy are applied, and with the development of the treatment method, the treatment performance has improved dramatically, and the 5-year survival rate of more than 80% is currently recorded. Due to the improvement in survival rate, interest in side effects caused by cancer treatment itself is gradually increasing, and efforts to reduce them are increasing. Accordingly, it aims to contribute to improving the quality of life of pediatric solid cancer survivors. by developing a Korean-type early diagnosis and follow-up protocol of ototoxic hearing loss, which commonly occurs in pediatric solid cancer who have undergone chemotherapy.

NCT ID: NCT05628285 Active, not recruiting - Clinical trials for Conductive Hearing Loss

Evaluation of a Hearing Device for Transmitting Sound to the Inner Ear

Start date: November 15, 2022
Phase: N/A
Study type: Interventional

A single center study evaluating the performance of an externally worn sound processor for a transcutaneous bone anchored hearing system using audiological outcomes measures such as aided thresholds and self-evaluation questionnaires.

NCT ID: NCT05628233 Recruiting - Clinical trials for Hearing Loss Ototoxic

SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease

NOTOXIS
Start date: December 30, 2022
Phase: Phase 2
Study type: Interventional

This study is intended to evaluate the ability of SENS-401 to prevent the ototoxicity induced by cisplatin in subjects with a neoplastic disease. It is a multicenter, randomized, controlled, two-arm, open-label efficacy and safety study in adults with neoplastic disease requiring treatment with cisplatin as part of the chemotherapy protocol plan.

NCT ID: NCT05623384 Recruiting - Sudden Deafness Clinical Trials

Effect of Ultrasound-guided Stellate Ganglion Block Combined With Facial Nerve and Glossopharyngeal Nerve Block on the Treatment of Sudden Deafness

Start date: November 14, 2022
Phase: N/A
Study type: Interventional

Sudden deafness is a sudden, unexplained sensorineural hearing loss of ≥20 dBHL in at least two adjacent frequencies within 72 h. It may be accompanied by tinnitus, a sense of ear congestion, vertigo and other Symptoms.Stellate ganglion block increases the blood flow and blood velocity in the inner ear, keeping the body's vegetative, endocrine and immune functions normal.The branches of the facial and linguopharyngeal nerves are connected to the inner ear, and local injection can nourish the nerves and improve local circulation.

NCT ID: NCT05621798 Recruiting - Clinical trials for Sensorineural Hearing Loss, Bilateral

Quantifying the Benefits and Cost-effectiveness of Real-Ear Measurements (REM) for Hearing Aid Fitting

BREM
Start date: September 7, 2022
Phase: N/A
Study type: Interventional

Adjusting hearing aid user's real ear performance by using probe-microphone technology (real ear measurement, REM) has been a well-known procedure that verifies whether the output of the hearing aid at the eardrum matches the desired prescribed target. Still less than half of audiologists verify hearing aid fitting to match the prescribed target amplification with this technology. Recent studies have demonstrated failures to match the prescribed amplification targets, using exclusively the predictions of the proprietary software. American Speech-Language-Hearing Association (ASHA) and American Academy of Audiology (AAA) have created Best Practice Guidelines that recommend using real-ear measurement (REM) over initial fit approach and also the recent ISO 21388:2020 on hearing aid fitting management recommends the routine use of REM. Still audiologists prefer to rely on the manufacturer's default "first-fit" settings because of the lack of proof over cost-effectiveness and patient outcome in using REM. There are only few publications of varying levels of evidence indicating benefits of REM-fitted hearing aids with respect to patient outcomes that include self-reported listening ability, speech intelligibility in quiet and noise and patients' preference. Our main research question is whether REM-based fitting improves the patient reported outcome measures - PROMs (SSQ, HERE) and performance-based outcome measures (speech-reception threshold in noise) over initial fit approach. An additional research question is whether REM-based fitting improves hearing aid usage (self-reported & log-data report). Eventually, the investigators will calculate the cost-effectiveness of REM-based fitting.

NCT ID: NCT05619575 Completed - Hearing Impairment Clinical Trials

Acceptance and Performance of the CP1170 Sound Processor in Experienced Adult Cochlear Implant Recipients (POLAR)

POLAR
Start date: December 20, 2022
Phase: N/A
Study type: Interventional

Acceptance and performance of the CP1170 sound processor in experienced adult cochlear implant recipients compared with the CP1150 sound processor and their current sound processor.

NCT ID: NCT05615649 Recruiting - Clinical trials for Hearing Loss, Conductive

Expanded Indications in the Pediatric BONEBRIDGE Population

Start date: October 3, 2023
Phase: N/A
Study type: Interventional

This study will assess safety and efficacy of the MED-EL BONEBRIDGE Bone Conduction Implant in children under 12 years old with conductive or mixed hearing loss.

NCT ID: NCT05612763 Completed - Clinical trials for Hearing Loss, Sensorineural

Self Fitting Hearing Aid Clinical Investigation

Start date: August 18, 2022
Phase: N/A
Study type: Interventional

Pre-market Clinical Investigation whose primary purpose is to evaluate efficacy and effectiveness of self-fitting hearing aids